2021 PQG Conference: From COVID-19 Genomics to Spread, Vaccine, and Therapy

Thursday, October 28, 2021

9:00-9:10 Opening Remarks, Stellar Abstract Awards
Xihong Lin, Conference Chair

SESSION I: Viral Genomics and Phylogenetics
Co-Chairs: Jeff Barrett and Kyle Vogan

* last 5 minutes of all session talks reserved for questions and discussion

9:10-10:00
Emma Hodcroft | KEYNOTE SPEAKER
University of Bern
Real-time to Real-life: Phylogenetics & SARS-CoV-2 Variant Tracking

10:00-10:30
Moritz Kraemer | University of Oxford
Context specific emergence of VOCs Alpha and Delta

10:30-10:45
Irwin Jungreis  | Abstract Winner Platform Talk I
Massachusetts Institute of Technology
SARS-COV-2 gene content and COVID-19 mutation impact by comparing 44  Sarebecovirus genomes

10:45-11:10  BREAK

11:10-11:40
Verity Hill | University of Edinburgh
The origins, evolution and spread of B.1.1.7 in the UK

11:40-12:10
Kristian Andersen | Scripps Research
The origin and evolution of SARS-CoV-2 – what does the evidence tell us

12:10-1:15  LUNCH BREAK

SESSION II: SarsCov2 and the Host
Co-Chairs: Priya Duggal and Andrea Ganna 

1:15-2:05
Ben Neale| KEYNOTE SPEAKER
Broad Institute
COVID Host Genetics Initiative

2:05-2:35
Brent Richards | McGill University
OAS1 as a Protein Influencing COVID-19 Severity: Results from Human Genetics and Proteomics

2:35-3:05
George Davey Smith | University of Bristol
Mendelian randomization: what (if anything) can it add to covid-19 research?

3:05-3:30 BREAK

3:30-3:45
Georg Hahn | Abstract Winner Platform Talk II
Harvard T.H. Chan School of Public Health
Genome‐wide association analysis of COVID‐19 mortality risk

3:45-4:15
Aviv Regev | Genentech Inc
A COVID-19 cross tissue atlas reveals SARS-CoV-2 pathology and cellular targets

4:15-6:00 Virtual Poster Session

Friday, October 29, 2021

SESSION III: Vaccine Genomics and Virology
Co-Chairs: David Benkeser and William Hanage

9:00-9:50
Bette Korber | KEYNOTE SPEAKER
Los Alamos National Lab
SARS CoV-2 Evolution and Variants: Lessons from the Past, Anticipating the Future

9:50-10:20
Sarah Cobey | University of Chicago
The risk of vaccine-induced evolution in SARS-CoV-2

10:20-10:40  BREAK

10:40-10:55
Nerea Zabaleta | Abstract Winner Platform Talk III
Massachusetts Eye and Ear Infirmary
AAVCOVID: A single-dose, room-temperature stable COVID-19 vaccine with durable immunogenicity

10:55-11:25
Peter Gilbert | Fred Hutch
Statistical Evaluation of Immune Correlates of Protection in the Moderna COVE COVID-19 Vaccine Efficacy Trial

11:25-11:55
Penny Moore | University of Witswatersrand and CAPRISA
Humoral immune responses to SARS-CoV-2 variants

11:55-12:00 Closing Remarks
Xihong Lin, Conference Chair

News from the School

The power of storytelling in public health